Fund Holdings — Foresite Capital Management IV, LLC

Total Portfolio Value
$153.01M
Total Bought
$7.80M
Total Sold
$0
Net Transaction
+$7.80M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Relay Therapeutics Inc.(RLAY)01,000,000+1,000,00007,0804.63%+7,080
Pharvaris N.V.
COM
4,293,8544,397,881+104,02780,72481,44953.23%+724
Lyell Immunopharma, Inc.(LYEL)8,325,0008,325,000012,07111,4897.51%-583
Syndax Pharmaceuticals, Inc.(SNDX)875,000875,000017,96416,84411.01%-1,120
Kura Oncology, Inc.(KURA)1,849,9471,849,947038,09036,14823.62%-1,942
Page 1 of 1
Foresite Capital Management IV, LLC — 13F Holdings — Q3 2024 | TickerTrail